Supplementary Figure S3 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
Year: 2025
Type: supplementary-materials
Abstract: Validation of depletion of CD99 in DMG cells by Western blotting and flow cytometry. Evaluation of functional effects of CD99-depleted cells, using cell proliferation assays, stemness by Aldefluor assay, differentiation by qRT-PCR, in vivo tumor growth inhibition, and apoptotic and differentiation markers.
Authors: Ilango Balakrishnan, Krishna Madhavan, Angela Pierce, Joshua Michlin, Breauna Brunt, Senthilnath Lakshmanachetty, Dong Wang, John DeSisto, Zachary James Nuss, Nathan Davidson, Faye Walker, Ammu Suresh, Andrew Donson, Bridget Sanford, Kenneth L. Jones, Etienne P. Danis, Siddhartha S. Mitra, Adam L. Green, Nathan Dahl, Rajeev Vibhakar, Sujatha Venkataraman
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4413380932